![](/img/cover-not-exists.png)
398 Efficacy and safety of ixekizumab for the treatment of plaque psoriasis: Results through 108 weeks randomised, phase III clinical trial (UNCOVER-3)
Blauvelt, A., Gooderham, M., Iversen, L., Ball, S., Zhang, L., Agada, N., Reich, K., Dossenbach, M.Volume:
137
Language:
english
Journal:
Journal of Investigative Dermatology
DOI:
10.1016/j.jid.2017.07.593
Date:
October, 2017
File:
PDF, 428 KB
english, 2017